For research use only
| Cat No. | ABC-TC3531 |
| Product Type | Osteoblasts |
| Cell Type | Osteoblast |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cartilage |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human Calvarial Osteoblast from AcceGen Research Laboratories are isolated from human calvariae.
Human Calvarial Osteoblasts (HCOs) are derived from human calvarial bone tissue and cryopreserved following primary culture. HCOs display a polygonal morphology and adherent growth pattern. These cells play a crucial role in bone formation and remodeling by synthesizing and secreting the organic bone matrix (osteoid), which subsequently mineralizes to form mature bone tissue. HCOs are widely used in skeletal biology research, particularly in studies of bone metabolism, osteogenesis, and the development of osteoporosis therapies. These cells exhibit a high level of phosphatase activity and mineral deposition. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | Human Calvarial Osteoblasts, Skull Osteoblasts Human, Calvaria Derived Osteoblasts, Human Cranial Osteoblasts, HCOBs |
| Species | Human |
| Cat.No | ABC-TC3531 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Osteoblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cartilage |
| Disease | Normal |
| Storage | Liquid Nitrogen |
| Product Type | Osteoblasts |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Calvarial Osteoblasts are vital for exploring bone formation, remodeling, and the molecular mechanisms of skeletal diseases such as osteoporosis and craniosynostosis. These cells secrete osteoid, the unmineralized matrix that later becomes calcified. Researchers frequently use them to evaluate osteogenic differentiation, bone tissue engineering strategies, and the effects of bioactive molecules or gene modulation on osteoblast function.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).